A Phase II Trial of MOnaliZumab in Combination With durvAlumab (MEDI4736) for tReatmenT of Small Cell Lung Cancer (MOZART)
NCT05903092 · SUSPENDED · Phase 2
We track 1 ClinicalTrials.gov studies led by Hirva Mamdani. The portfolio skews toward Phase 2 (1 trials).
1 clinical trials sponsored by Hirva Mamdani.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 100% |
Hirva Mamdani currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 2.
Hirva Mamdani conducts research across multiple therapeutic areas. Browse the trial listings for details.
Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.